BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35064062)

  • 1. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
    Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N
    Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
    Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
    Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.
    Hinić S; Rich A; Anayannis NV; Cabarcas-Petroski S; Schramm L; Meneses PI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
    Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
    J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases.
    Zygouras I; Leventakou D; Pouliakis A; Panagiotou S; Tsakogiannis D; Konstantopoulos G; Logotheti E; Samaras M; Kyriakopoulou Z; Beloukas A; Pateras IS; Delides A; Psyrri A; Panayiotides IG; Yiangou M; Kottaridi C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
    Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
    Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
    Bzhalava Z; Arroyo Mühr LS; Dillner J
    Vaccine; 2020 May; 38(25):4066-4070. PubMed ID: 32362526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.
    Rettig EM; Faden DL; Sandhu S; Wong K; Faquin WC; Warinner C; Stephens P; Kumar S; Kuperwasser C; Richmon JD; Uppaluri R; Varvares M; Sethi R; Hanna GJ; Sroussi H
    Int J Cancer; 2022 Oct; 151(7):1081-1085. PubMed ID: 35262203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.
    Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA
    PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
    Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
    Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
    Mainguené J; Vacher S; Kamal M; Hamza A; Masliah-Planchon J; Baulande S; Ibadioune S; Borcoman E; Cacheux W; Calugaru V; Courtois L; Crozes C; Deloger M; Girard E; Delord JP; Dubray-Vautrin A; Larbi Chérif L; Dupain C; Jeannot E; Klijanienko J; Lameiras S; Lecerf C; Modesto A; Nicolas A; Rouzier R; Saada-Bouzid E; Saintigny P; Sudaka A; Servant N; Le Tourneau C; Bièche I
    Mol Oncol; 2022 Aug; 16(16):3001-3016. PubMed ID: 35398964
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenic activation around HPV integrated sites in head and neck squamous cell carcinoma.
    Mima M; Okabe A; Hoshii T; Nakagawa T; Kurokawa T; Kondo S; Mizokami H; Fukuyo M; Fujiki R; Rahmutulla B; Yoshizaki T; Hanazawa T; Misawa K; Kaneda A
    Int J Cancer; 2023 May; 152(9):1847-1862. PubMed ID: 36650703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
    Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
    Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.
    Agrawal Y; Koch WM; Xiao W; Westra WH; Trivett AL; Symer DE; Gillison ML
    Clin Cancer Res; 2008 Nov; 14(21):7143-50. PubMed ID: 18981014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.